CAM Regulations – A Bitter Pill for Emerging Businesses: Dissecting SAHPRA’s Regulation on Complementary Medicines
Analysis Report: SAHPRA’s Regulatory Overreach on Complementary Medicines Issued by the TNHA Introduction Ladies and gentlemen, let’s talk about the South African Health Products Regulatory Authority (SAHPRA) and their latest move — a draft Road Map guideline for regulating what they call ‘category D medicines.’ Now, you won’t find this easily; it’s tucked away on their website, with a comment period open until October 17, 2023. But don’t be fooled, they’re not playing by the... Read More